Abstract
The multidrug resistance (MDR) proteins that belong to the ATP-binding cassette superfamily such as Pglycoprotein (P-gp) and MRP1, are present in a majority of human tumors and constitute an important cause of therapeutic failure. Selective inhibitors of the MDR-efflux proteins may improve the effectiveness of cancer chemotherapy. Their mechanism of action was believed to be a competition between resistance modifiers and drugs for the same binding site of P-gp. In our previous work we studied modulation of MDR in cancer cells expressing P-gp or MRP1 by selected carotenoids, flavonoids and extracts from medically important Chinese plants. Capsanthin and capsorubin, carotenoids isolated from paprika, were identified as potent P-gp inhibitors, while lycopene, lutein, antheraxanthin and violaxanthin induced moderate effects. Among flavonoids, effective modulators were rotenone, chrysin, phloretin and sakuranetin. Some chloroform extracts of Chinese herbs were also found to inhibit MDR efflux pumps. The effects of the modulators on Pgp activity were studied by measuring rhodamine 123 uptake in several cancer cells such as the human MDR1 genetransfected mouse lymphoma cells (L1210) and human breast cancer cells MDA-MB-231 expressing the MRP1 pump (HTB26). Additionally, the ability to alter biophysical properties of lipid bilayers by selected carotenoids was studied by differential scanning calorimetry. The antiproliferative effects as well as the MDR reversal activity of the studied compounds, applied in combination with anticancer drugs, were also discussed.
Keywords: Human cytomegalovirus (CMV), Ganoderma, Atractylodes, Codonopsis, Ginseng, Ligustrum, Astragalus, Glutathione (GSH), 6a,12a-dehydroamorphigenin, Afrormosin, (+)-12a-hydroxyamorphigenin, Capsicum annum L., Multiple Pharmacological Targets, Differential scanning calorimetry (DSC), MCF7/MDR1 cells, Diepoxy-β-carotene, Mutatochrome, HTB26 cells, α- and b-cryptoxanthines, Antheraxanthin, Zeaxanthin, Lutein, Lycopene, Violaxanthin, Lycophyll, Capsorubin, Capsanthin, Rhodamine 123, Cancer chemotherapy, β-carotene, Promyelocytic leukemia, Breast cancer resistance protein (BCRP), Pglycoprotein (P-gp), ATP-binding cassette, Traditional Chinese medicinal plants, Synergistic interactions, Resistance modifiers, Multidrug resistance (MDR), Mouse lymphoma cells transfected with human MDR1 gene, Human breast- and colon cancer, Flavonoids, Carotenoids
Current Topics in Medicinal Chemistry
Title: Reversal of Multidrug Resistance by Natural Substances from Plants
Volume: 10 Issue: 17
Author(s): Q. Wang, K. Michalak, O. Wesolowska, J. Deli, P. Molnar, J. Hohmann, J. Molnar and H. Engi
Affiliation:
Keywords: Human cytomegalovirus (CMV), Ganoderma, Atractylodes, Codonopsis, Ginseng, Ligustrum, Astragalus, Glutathione (GSH), 6a,12a-dehydroamorphigenin, Afrormosin, (+)-12a-hydroxyamorphigenin, Capsicum annum L., Multiple Pharmacological Targets, Differential scanning calorimetry (DSC), MCF7/MDR1 cells, Diepoxy-β-carotene, Mutatochrome, HTB26 cells, α- and b-cryptoxanthines, Antheraxanthin, Zeaxanthin, Lutein, Lycopene, Violaxanthin, Lycophyll, Capsorubin, Capsanthin, Rhodamine 123, Cancer chemotherapy, β-carotene, Promyelocytic leukemia, Breast cancer resistance protein (BCRP), Pglycoprotein (P-gp), ATP-binding cassette, Traditional Chinese medicinal plants, Synergistic interactions, Resistance modifiers, Multidrug resistance (MDR), Mouse lymphoma cells transfected with human MDR1 gene, Human breast- and colon cancer, Flavonoids, Carotenoids
Abstract: The multidrug resistance (MDR) proteins that belong to the ATP-binding cassette superfamily such as Pglycoprotein (P-gp) and MRP1, are present in a majority of human tumors and constitute an important cause of therapeutic failure. Selective inhibitors of the MDR-efflux proteins may improve the effectiveness of cancer chemotherapy. Their mechanism of action was believed to be a competition between resistance modifiers and drugs for the same binding site of P-gp. In our previous work we studied modulation of MDR in cancer cells expressing P-gp or MRP1 by selected carotenoids, flavonoids and extracts from medically important Chinese plants. Capsanthin and capsorubin, carotenoids isolated from paprika, were identified as potent P-gp inhibitors, while lycopene, lutein, antheraxanthin and violaxanthin induced moderate effects. Among flavonoids, effective modulators were rotenone, chrysin, phloretin and sakuranetin. Some chloroform extracts of Chinese herbs were also found to inhibit MDR efflux pumps. The effects of the modulators on Pgp activity were studied by measuring rhodamine 123 uptake in several cancer cells such as the human MDR1 genetransfected mouse lymphoma cells (L1210) and human breast cancer cells MDA-MB-231 expressing the MRP1 pump (HTB26). Additionally, the ability to alter biophysical properties of lipid bilayers by selected carotenoids was studied by differential scanning calorimetry. The antiproliferative effects as well as the MDR reversal activity of the studied compounds, applied in combination with anticancer drugs, were also discussed.
Export Options
About this article
Cite this article as:
Wang Q., Michalak K., Wesolowska O., Deli J., Molnar P., Hohmann J., Molnar J. and Engi H., Reversal of Multidrug Resistance by Natural Substances from Plants, Current Topics in Medicinal Chemistry 2010; 10 (17) . https://dx.doi.org/10.2174/156802610792928103
DOI https://dx.doi.org/10.2174/156802610792928103 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Challenges, Consequences and Possible Treatments of Anticancer Drug Discovery ll
The use of several compounds has been the subject of increasing interest in phytochemistry, biochemistry, and other fields of research at the chemistry-biology-ecosystems interface. In spite of the continued search for new anticancer drugs, cancer remains a leading cause of death. Cancer mortalities are expected to increase to 12.9 million, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor
Current Drug Targets A Facile Total Synthesis of Kilogram-Scale Production of SKLB1039: A Novel and Selective Hexahydroisoquinolin-Containing EZH2 Inhibitor
Current Organic Synthesis Oral Nano-Delivery Systems for Colon Targeting Therapy
Pharmaceutical Nanotechnology Synthesis, SAR and Biological Evaluation of Natural and Non-natural Hydroxylated and Prenylated Xanthones as Antitumor Agents
Medicinal Chemistry Probiotic Properties of a Spaceflight-induced Mutant Lactobacillus Plant- arum SS18-50 in Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets Modulation of Apoptosis: New Opportunities for Drug Discovery to Treat Autoimmune Thyroiditis
Recent Patents on Inflammation & Allergy Drug Discovery Activation of the Innate Immune System in Atherosclerotic Disease
Current Pharmaceutical Design On Mechanisms of Reactive Metabolite Formation from Drugs
Mini-Reviews in Medicinal Chemistry Automated Detection of Breast Tumor in Different Imaging Modalities: A Review
Current Medical Imaging Three-Dimensional Manufactured Supports for Breast Cancer Stem Cell Population Characterization
Current Drug Targets Cardiovascular Effects of Neuregulin-1/ErbB Signaling: Role in Vascular Signaling and Angiogenesis
Current Pharmaceutical Design Flavonoids and the Brain: Evidences and Putative Mechanisms for a Protective Capacity
Current Neuropharmacology Novel Pharmacologic Approaches to the Prevention and Treatment of Ulcerative Colitis
Current Pharmaceutical Design Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
Current Drug Targets Recent Advances in the Development of Immunoadhesins for Immune Therapy and as Anti-Infective Agents
Recent Patents on Anti-Infective Drug Discovery Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Microarrays and Colon Cancer in the Road for Translational Medicine
Current Bioinformatics Signaling Pathways in Inflammation and Anti-inflammatory Therapies
Current Pharmaceutical Design Targeting Histone Onco- Modifications Using Plant-Derived Products
Current Drug Targets DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
Current Pharmacogenomics